Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
US11957788B2 · kind B2 · utility
0Cited by
300References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2021 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Oct 31, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.